Archived edition · Bangkok time
Microsoft integrates open-source OpenClaw framework into enterprise cloud Copilot Autopilot, while Toregem BioPharma and Kyoto University advance the TRG035 tooth regeneration antibody trial into Phase IIa.
3 unique stories
This marks a major paradigm shift where enterprise tech adopts an open-source agent framework at its architectural core, giving businesses autonomous, permission-governed background execution across productivity platforms.
If clinically validated, neutralizing USAG-1 offers the world's first biological alternative to titanium dental implants and dentures, potentially disrupting dental supply chains and medical tourism dynamics across Asia.
If anti-competitive pacing exists, it could trigger major regulatory antitrust interventions; if false, it highlights escalating corporate tension as efficient alternatives erode proprietary margins.